The Latest Articles from Streetwise Reports


Aravive Shares Rise on Positive Patient Data from Phase 1b Ovarian Cancer Study

  ()
Shares of Aravive Inc. traded higher after the firm posted positive data from the initial 12 patients enrolled in the Phase 1b portion of its study of AVB-500 used in the treatment of ovarian cancer. read more >

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results

  ()
Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. read more >

Shares Rise as The Medicines Company Reports Positive Topline Results from Two Phase 3 Cholesterol Trials

  ()
The Medicines Company's shares traded 8.5% higher after the firm reported positive results from two phase 3 studies for inclisiran, one for familial hypercholesterolemia, which leads to high levels of LDL-C, and one for atherosclerotic cardiovascular disease. read more >

PhaseBio Shares Are on a Tear After Reporting Phase 2a Trial Results

  ()
The clinical-stage biopharmaceutical stock surged more than 30% Wednesday following a report that PB2452 caused immediate and sustained reversal of ticagrelor in older and elderly subjects. read more >

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

  ()
Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. read more >

Analyst: Acquisition by Colorado-Based Specialty Pharma 'Could Bolster Revenue 400%'

Research Report
  ()
The benefits and terms of the agreement are outlined in a Ladenburg Thalmann report. read more >

Avadel Pharma Shares Up 30% Upon Acceleration of Phase 3 REST-ON Study

  ()
Avadel Pharmaceuticals' shares trades 30% higher on news that the FDA agreed to reduce the sample size required for its Phase 3 REST-ON study, accelerating its completion by year-end 2019. read more >
News Update

Cannabis Company Expands Operations with New Plant

News Update
  ()
The firm will use this second manufacturing facility only for making reagents. read more >
News Update

Mobile Health, Telemedicine Solutions Firm Lands Five New Clients

News Update
  ()
With these new contracts, the Vancouver-based company continues to build its momentum in Texas. read more >

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation

  ()
Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Products for Human Use also adopted a positive opinion for Dupixent in a third indication. read more >
News Update

Biopharma Reports Positive Data from Alcoholic Hepatitis Study

News Update
  ()
These results are from the recently completed clinical trial of the firm's lead drug candidate. read more >

NCI Chooses Veterinary Biopharma as Select Manufacturing Contractor

Research Report
  ()
The contract's meaning, terms and benefits and the California firm's near-term catalysts are discussed in an H.C. Wainwright & Co. report. read more >

Alder BioPharmaceuticals Shares Surge 80% on Acquisition News

  ()
Shares of migraine treatment research firm Alder BioPharmaceuticals soared 84% after the company announced that it has agreed to be acquired by H. Lundbeck for $1.95 billion. read more >

Fibrocell Science Shares Rise 60% on Acquisition News

  ()
Fibrocell Science's shares traded up 60% after the company announced that it agreed to be acquired by Castle Creek Holdings for $63.3 million, or $3.00 per share. read more >
News Update

Healthcare Company Rolls Out Patient App Access to Electronic Medical Records System

News Update
  ()
This is one way the Canadian firm is providing convenient, patient-centric service. read more >

Moderna Shares Rise on the Release of Positive Results from Two mRNA Phase 1 Programs

  ()
Shares of Moderna Inc. traded up double-digits as the firm announced results from its Phase 1 CMV Vaccine Study as well as its Phase 1 data for mRNA-1944 encoding for antibody against the chikungunya virus. read more >
News Update

Company Develops Cannabinoid-Measuring Process for Liquids

News Update
  ()
This proprietary method ensures the firm meets the requirements for its cannabis-containing beverages and oils. read more >

Sanofi Pays Lexicon Pharma $260 Million to Settle Diabetes Drug Dispute

  ()
Lexicon Pharmaceuticals shares traded higher by more than 30% after the company announced termination of its alliance with Sanofi SA and a $260 million settlement over its diabetes drug Zynquista. read more >

Biopharma Makes Licensing Deal for Therapeutic Rights in Japan

Research Report
  ()
The company's reasons for the transaction and expected short-term, stock-moving events are provided in a ROTH Capital Partners report. read more >

T2 Biosystems Receives BARDA Contract to Fight Antimicrobial Resistance, Shares Up More than 88%

  ()
This healthcare diagnostics stock rose more than 88% on Wednesday following the award of a BARDA contract that could be worth up to $69 million. read more >

Mallinckrodt Shares Up 60% as It Announces Sale of Unit

  ()
Shares of Mallinckrodt Plc traded more than 60% higher on news that the company is selling its CDMO subsidiary BioVectra Inc. to H.I.G. Capital for $250 million. read more >

ACADIA Pharma's Shares Open 75% Higher on Positive Anti-Psychosis Drug Phase 3 Results

  ()
Shares of ACADIA Pharmaceuticals opened up 75% higher after the company announced that its Phase 3 Study of pimavanserin for the treatment of dementia-related psychosis met its primary endpoint. read more >
News Update

Technology License Triggers $10 Million Milestone Payment for Biopharma

News Update
  ()
This is the first of many such potential payments under the related agreement. read more >

Neon Therapeutics Shares Are Flashing Brightly after Reporting Predictive Cancer Breakthrough

  ()
After announcing publication in the scientific journal Immunity that it had created a 61-fold improvement process for predicting cancer-specific antigens, Neon Therapeutics' stock has traded wildly, up more than 46% at times on nearly 100-times average daily volume, but has since pulled back greatly. read more >

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

  ()
Shares of Global Blood Therapeutics traded more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. read more >
Showing Results: 26 to 50 of 159 Prev Next

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts